These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31420082)

  • 1. Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study.
    Cuello JP; Salgado Cámara P; García Domínguez JM; Lozano Ros A; Mas Serrano M; Martínez Ginés ML
    Med Clin (Barc); 2020 Mar; 154(6):214-217. PubMed ID: 31420082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
    Thiel S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):801-9. PubMed ID: 26920382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glatiramer acetate during early pregnancy: A prospective cohort study.
    Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
    Pecori C; Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Sturchio A; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; Mancardi GL; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP;
    BMC Neurol; 2014 May; 14():114. PubMed ID: 24884599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.
    Andersen JB; Sellebjerg F; Magyari M
    Eur J Neurol; 2023 Jan; 30(1):162-171. PubMed ID: 36098960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
    Lu E; Dahlgren L; Sadovnick A; Sayao A; Synnes A; Tremlett H
    Mult Scler; 2012 Apr; 18(4):460-7. PubMed ID: 21914689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.
    Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelzstejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Siquineli F; Tosta ED
    CNS Drugs; 2013 Nov; 27(11):955-61. PubMed ID: 24114585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
    Fernández Liguori N; Klajn D; Acion L; Cáceres F; Calle A; Carrá A; Cristiano E; Deri N; Garcea O; Jaureguiberry A; Onaha P; Patrucco L; Riccio P; Rotta Escalante R; Saladino Ml; Sinay V; Tarulla A; Villa A
    Mult Scler; 2009 May; 15(5):555-62. PubMed ID: 19299437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes in pregnant women with epilepsy.
    Huang CY; Dai YM; Feng LM; Gao WL
    Epilepsy Behav; 2020 Nov; 112():107433. PubMed ID: 32919204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
    Cuello JP; Martínez Ginés ML; Martin Barriga ML; de Andrés C
    Neurologia; 2017 Mar; 32(2):92-98. PubMed ID: 25728948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Progression and Obstetric Outcomes of Women with Multiple Sclerosis at a Reference Center in Northeastern Brazil.
    Barros GMC; Oliveira BES; Oliveira GJ; Silva RKP; Cardoso TN; Maia SB
    Rev Bras Ginecol Obstet; 2021 Mar; 43(3):165-171. PubMed ID: 33860499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: management issues during pregnancy.
    Ferrero S; Pretta S; Ragni N
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    Burkill S; Vattulainen P; Geissbuehler Y; Sabido Espin M; Popescu C; Suzart-Woischnik K; Hillert J; Artama M; Verkkoniemi-Ahola A; Myhr KM; Cnattingius S; Korhonen P; Montgomery S; Bahmanyar S
    PLoS One; 2019; 14(12):e0227120. PubMed ID: 31887199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and factors affecting vaginal delivery of twins at University of Nigeria Teaching Hospital, Enugu.
    Nwankwo TO; Aniebue UU; Ezenkwele E; Nwafor MI
    Niger J Clin Pract; 2013; 16(4):490-5. PubMed ID: 23974745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
    MacDonald SC; McElrath TF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
    Fragoso YD; Boggild M; Macias-Islas MA; Carra A; Schaerer KD; Aguayo A; de Almeida SM; Alvarenga MP; Alvarenga RM; Alves-Leon SV; Arruda WO; Brooks JB; Comini-Frota ER; Ferreira ML; Finkelsztejn A; Finkelsztejn JM; de Freitas LD; Gallina AS; da Gama PD; Georgetto S; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Lourenco GA; Malfetano FR; Morales NM; Morales Rde R; Oliveira CL; Onaha P; Patroclo C; Ribeiro SB; Ribeiro TA; Salminen HJ; Santoro P; Seefeld M; Soares PV; Tarulla A; Vasconcelos CC
    Clin Neurol Neurosurg; 2013 Feb; 115(2):154-9. PubMed ID: 22633835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple sclerosis and childbirth: Relapse frequency and pregnancy outcome. A hospital-based retrospective study].
    Bergthorsdóttir BB; Thorhallsdottir RL; Steingrimsdottir T; Hjaltason H
    Laeknabladid; 2020 Desember; 106(12):581-589. PubMed ID: 33252050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
    Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
    BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
    Lopez-Leon S; Geissbühler Y; Sabidó M; Turkson M; Wahlich C; Morris JK
    J Neurol; 2020 Sep; 267(9):2721-2731. PubMed ID: 32444984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domestic violence and perinatal outcomes - a prospective cohort study from Nepal.
    Pun KD; Rishal P; Darj E; Infanti JJ; Shrestha S; Lukasse M; Schei B;
    BMC Public Health; 2019 May; 19(1):671. PubMed ID: 31151395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.